{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:21Z","timestamp":1786119381033,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1097\/shk.0b013e3181a2e279","type":"journal-article","created":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T03:31:52Z","timestamp":1254972712000},"page":"530-534","source":"Crossref","is-referenced-by-count":19,"title":["ENOXAPARIN ATTENUATES ENDOTHELIAL DAMAGE WITH LESS BLEEDING COMPARED WITH UNFRACTIONATED HEPARIN IN ENDOTOXEMIC RATS"],"prefix":"10.1097","volume":"32","author":[{"given":"Toshiaki","family":"Iba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210213","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":": Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"R2-12-20210213","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0038-1650173","article-title":"Studies in man and experimental animals of a low molecular heparin fraction.","volume":"45","author":"Thomas","year":"1981","journal-title":"Thromb Haemost"},{"key":"R3-12-20210213","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0049-3848(93)90109-2","article-title":"Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC): a multicenter cooperative double-blind trial in comparison with heparin.","volume":"72","author":"Sakuragawa","year":"1993","journal-title":"Thromb Res"},{"key":"R4-12-20210213","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis.","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-12-20210213","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/cc1854","article-title":"Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis.","volume":"7","author":"Opal","year":"2003","journal-title":"Crit Care"},{"key":"R6-12-20210213","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Current concepts. Disseminated intravascular coagulation.","volume":"341","author":"Levi","year":"1999","journal-title":"N Engl J Med"},{"key":"R7-12-20210213","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00003246-200002000-00027","article-title":"Coagulation system and platelets are fully activated in uncomplicated sepsis.","volume":"28","author":"Mavrommatis","year":"2000","journal-title":"Crit Care Med"},{"key":"R8-12-20210213","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/375593","article-title":": Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated).","volume":"37","author":"Opal","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R9-12-20210213","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0049-3848(90)90110-X","article-title":"The effect of heparin on multiple organ failure and disseminated intravascular coagulation in a sepsis model.","volume":"60","author":"Tanaka","year":"1990","journal-title":"Thromb Res"},{"key":"R10-12-20210213","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00003246-199301000-00017","article-title":"Heparin in experimental hyperdynamic sepsis.","volume":"21","author":"Meyer","year":"1993","journal-title":"Crit Care Med"},{"key":"R11-12-20210213","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1161\/01.CIR.100.25.2485","article-title":"Heparin blunts endotoxin-induced coagulation activation.","volume":"100","author":"Pernerstorfer","year":"1999","journal-title":"Circulation"},{"key":"R12-12-20210213","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/01.CCM.0000059441.70680.DC","article-title":"Evaluation of anti-inflammatory and antiadhesive effects of heparins in human endotoxemia.","volume":"31","author":"Derhaschnig","year":"2003","journal-title":"Crit Care Med"},{"key":"R13-12-20210213","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00024382-199804000-00007","article-title":"Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model.","volume":"9","author":"Darien","year":"1998","journal-title":"Shock"},{"key":"R14-12-20210213","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000093105","article-title":"Combinations of low doses of unfractionated heparin and of low-molecular-weight heparin prevent experimental venous thrombosis.","volume":"34","author":"Carelli","year":"2005","journal-title":"Pathophysiol Haemost Thromb"},{"key":"R15-12-20210213","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/01.TA.0000032946.36293.25","article-title":"Antithrombin modulates the leukocyte-endothelial cell interaction in the staphylococcal enterotoxin B-challenged mouse.","volume":"55","author":"Iba","year":"2003","journal-title":"J Trauma"},{"key":"R16-12-20210213","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":": A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients.","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"R17-12-20210213","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(07)60633-3","article-title":"The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.","volume":"369","author":"Sherman","year":"2007","journal-title":"Lancet"},{"key":"R18-12-20210213","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00024382-200202000-00013","article-title":"Factor Xa-inhibitor (DX-9065a) modulates the leukocyte-endothelial cell interaction in endotoxemic rat.","volume":"17","author":"Iba","year":"2002","journal-title":"Shock"},{"key":"R19-12-20210213","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/01.CCM.0000166370.94927.B6","article-title":"Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation.","volume":"33","author":"Slofstra","year":"2005","journal-title":"Crit Care Med"},{"key":"R20-12-20210213","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/01.shk.0000228800.56223.db","article-title":"Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice.","volume":"26","author":"Iba","year":"2006","journal-title":"Shock"},{"key":"R21-12-20210213","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1097\/01.ALC.0000078610.78390.2A","article-title":"Dalteparin sodium prevents liver injury due to lipopolysaccharide in rat through suppression of tumor necrosis factor-alpha production by Kupffer cells.","volume":"27","author":"Tsukada","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"R22-12-20210213","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/01.CCM.0000220764.10155.03","article-title":"Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.","volume":"34","author":"Harada","year":"2006","journal-title":"Crit Care Med"},{"key":"R23-12-20210213","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0037-1613240","article-title":"Role of microthrombus formation in the development of ischemia\/reperfusion-induced liver injury in rats.","volume":"88","author":"Okajima","year":"2002","journal-title":"Thromb Haemost"},{"key":"R24-12-20210213","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.transproceed.2005.03.134","article-title":"Ischemia and reperfusion injury in liver transplantation.","volume":"37","author":"Kupiec-Weglinski","year":"2005","journal-title":"Transplant Proc"},{"key":"R25-12-20210213","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/01.CCM.0000059441.70680.DC","article-title":"Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia.","volume":"31","author":"Derhaschnig","year":"2003","journal-title":"Crit Care Med"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SHK.0b013e3181a2e279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:07:04Z","timestamp":1786039624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00024382-200911000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e3181a2e279","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}